Traditional clinical diagnostics often rely on static reference intervals that fail to capture the dynamic trajectory of metabolic disease until symptomatic thresholds are breached. This latency contributes to significant "Allostatic Load"—the cumulative physiological wear and tear on the body. We propose the Burak Multiomics Framework, a bio-computational engine designed to transition healthcare from descriptive monitoring to predictive interception. By implementing a standardized "Vendor Neutral Reporting Architecture" (VNRA) and a deterministic "8-Layer Logic" based on discrete rate-of-change analysis, the framework calculates the velocity of biomarker deviation. This paper details the methodological transition from batch data ingestion to clinical stratification, governed by strict physiological validation gates to identify high-risk phenotypes such as Metabolic Syndrome and Pre-Diabetes approximately 8 weeks prior to conventional clinical
diagnosis.